市場調查報告書
商品編碼
1541827
2024-2032 年按應用(化學分析、藥物發現、藥物驗證等)和地區分類的化學資訊學市場報告Chemoinformatics Market Report by Application (Chemical Analysis, Drug Discovery, Drug Validation, and Others), and Region 2024-2032 |
IMARC Group年全球化學資訊學市場規模達63億美元。
化學資訊學是資訊科技(IT)的一個新領域,專注於化學資料的收集、儲存、分析和操作。化學資料包括小分子分子式、結構、性質、光譜以及生物和工業活動。化學資訊學有助於定義檔案資料協議並表示3D (3D) 分子結構,從而進一步實現對具有特定特徵的化合物的搜尋和比較。因此,它被廣泛應用於製藥行業,以發現和開發新穎的生物技術製程和產品。
目前,冠狀病毒病(COVID-19)的爆發是積極影響化學資訊學在抗病毒研究或發現該疾病療法中的應用的主要因素之一。除此之外,慢性病病例的激增以及隨之而來的新藥的需求也影響著市場的成長。研發 (R&D) 計畫不斷增加的投資也促進了對化學資訊學的需求,以驗證潛在的候選藥物以及有效管理分子和原子反應過程中產生的資料。此外,對個人化醫療的認知不斷增強正在推動市場成長。由於合成新藥時產生大量資料,領先的市場參與者正在整合化學資訊學中先進的資訊儲存和檢索技術。這有助於研究人員有效儲存有關物理特性、3D 分子和晶體結構、光譜特徵、化學反應途徑、分子官能基和對接位點以及其他參數的資訊。預計這些創新將推動市場成長。
The global chemoinformatics market size reached US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data includes small molecule formulas, structures, properties, spectra, and biological and industrial activities. Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features. As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
At present, the outbreak of coronavirus disease (COVID-19) represents one of the major factors positively influencing the utilization of chemoinformatics in anti-viral research or discovery of therapeutics against the disease. Apart from this, the surging cases of chronic diseases and the consequent need for novel drugs are also influencing the market growth. The increasing investments in research and development (R&D) projects are also catalyzing the demand for chemoinformatics to validate potential drug candidates and the effective management of data generated during molecular and atomic reactions. Moreover, the increasing awareness about personalized medicine is driving the market growth. Due to the massive amount of data generated while synthesizing new drugs, the leading market players are integrating advanced information storage and retrieval technologies in chemoinformatics. This helps researchers in efficiently storing information about the physical properties, 3D molecular and crystal structures, spectroscopic signatures, chemical reaction pathways, molecular functional groups and docking sites, and other parameters. These innovations are anticipated to propel the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chemoinformatics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on application.
Chemical Analysis
Drug Discovery
Drug Validation
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systemes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrodinger Inc.